These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10448832)

  • 41. Tolerability of tiagabine: a prospective open-label study.
    Bauer J; Bergmann A; Reuber M; Stodieck SR; Genton P
    Epileptic Disord; 2002 Dec; 4(4):257-60. PubMed ID: 12600812
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tiagabine monotherapy in the treatment of partial epilepsy.
    Schachter SC
    Epilepsia; 1995; 36 Suppl 6():S2-S6. PubMed ID: 8595789
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tiagabine-induced nonconvulsive status epilepticus in an adolescent without epilepsy.
    Jette N; Cappell J; VanPassel L; Akman CI
    Neurology; 2006 Oct; 67(8):1514-5. PubMed ID: 17060592
    [No Abstract]   [Full Text] [Related]  

  • 44. Tiagabine-induced stupor - more evidence for an encephalopathy.
    Hamandi K; Myers J; Muthukumaraswamy S
    Epilepsy Behav; 2014 Feb; 31():196-7. PubMed ID: 24440890
    [No Abstract]   [Full Text] [Related]  

  • 45. Tiagabine.
    Schachter SC
    Epilepsia; 1999; 40 Suppl 5():S17-22. PubMed ID: 10530690
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [symbol: see text] Tiagabine: add-on treatment for partial seizures.
    Drug Ther Bull; 2000 Jun; 38(6):47-8. PubMed ID: 10912300
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tiagabine overdose: a case of status epilepticus in a non-epileptic patient.
    Fulton JA; Hoffman RS; Nelson LS
    Clin Toxicol (Phila); 2005; 43(7):869-71. PubMed ID: 16440516
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recurrent complex partial status epilepticus associated with tiagabine rechallenge.
    Brouns R; Van Paesschen W
    Acta Neurol Belg; 2002 Mar; 102(1):19-20. PubMed ID: 12094558
    [No Abstract]   [Full Text] [Related]  

  • 49. International experience with tiagabine add-on therapy.
    Ben-Menachem E
    Epilepsia; 1995; 36 Suppl 6():S14-S21. PubMed ID: 8595788
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tiagabine add-on for drug-resistant partial epilepsy.
    Pereira J; Marson AG; Hutton JL
    Cochrane Database Syst Rev; 2002; (3):CD001908. PubMed ID: 12137637
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term effects of tiagabine monotherapy on cognition and mood in adult patients with chronic partial epilepsy.
    Aikiä M; Jutila L; Salmenperä T; Mervaala E; Kälviäinen R
    Epilepsy Behav; 2006 Jun; 8(4):750-5. PubMed ID: 16647884
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term cognitive and EEG effects of tiagabine in drug-resistant partial epilepsy.
    Kälviäinen R; Aikiä M; Mervaala E; Saukkonen AM; Pitkänen A; Riekkinen PJ
    Epilepsy Res; 1996 Nov; 25(3):291-7. PubMed ID: 8956929
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety of tiagabine: summary of 53 trials.
    Leppik IE; Gram L; Deaton R; Sommerville KW
    Epilepsy Res; 1999 Feb; 33(2-3):235-46. PubMed ID: 10094434
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tiagabine prevents seizures, neuronal damage and memory impairment in experimental status epilepticus.
    Halonen T; Nissinen J; Jansen JA; Pitkänen A
    Eur J Pharmacol; 1996 Mar; 299(1-3):69-81. PubMed ID: 8901009
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [GEOS (Gabitril Epilepsy Observational Study) -- Polish results of the international study of tiagabine in partial epilepsy].
    Niedzielska K
    Neurol Neurochir Pol; 2005; 39(6):459-65. PubMed ID: 16355303
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Monitoring of renal function in epileptic children and teenagers treated with valproic acid or carbamazepine in concomitant therapy with tiagabine].
    Hurkacz M; Wiela-Hojeńska A; Orzechowska-Juzwenko K; Kozik A; Unolt J
    Pol Merkur Lekarski; 2001 Dec; 11(66):480-3. PubMed ID: 11899842
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of the cognitive effects of tiagabine and carbamazepine as monotherapy in newly diagnosed adult patients with partial epilepsy: pooled analysis of two long-term, randomized, follow-up studies.
    Aikiä M; Jutila L; Salmenperä T; Mervaala E; Kälviäinen R
    Epilepsia; 2006 Jul; 47(7):1121-7. PubMed ID: 16886974
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tiagabine-induced myoclonic status epilepticus in a nonepileptic patient.
    Vollmar C; Noachtar S
    Neurology; 2007 Jan; 68(4):310. PubMed ID: 17242344
    [No Abstract]   [Full Text] [Related]  

  • 59. Antiepileptic effects of tiagabine, a selective GABA uptake inhibitor, in the rat kindling model of temporal lobe epilepsy.
    Morimoto K; Sato H; Yamamoto Y; Watanabe T; Suwaki H
    Epilepsia; 1997 Sep; 38(9):966-74. PubMed ID: 9579934
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of twice- and three times daily tiagabine for the adjunctive treatment of partial seizures in refractory patients with epilepsy: an open label, randomised, parallel-group study.
    Biraben A; Beaussart M; Josien E; Pestre M; Savet JF; Schaff JL; Tourniaire D; Sevestre M; Renault-Djouadi J
    Epileptic Disord; 2001 Jun; 3(2):91-100. PubMed ID: 11431171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.